These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29242561)

  • 1. Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance.
    Shen Z; Yang H; Yang S; Wang W; Cui X; Zhou X; Liu W; Pan S; Liu Y; Zhang J; Zhang J; Xie Y; Liu J
    Nat Commun; 2017 Dec; 8(1):2119. PubMed ID: 29242561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models.
    Shen Z; Liu J; Wu J; Zhu Y; Li G; Wang J; Luo M; Deng Q; Zhang J; Xie Y
    Theranostics; 2019; 9(13):3798-3811. PubMed ID: 31281514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral backbone-based hepatitis B virus replicon-mediated transfer favours the establishment of persistent hepatitis B virus infection in mice after hydrodynamic injection.
    Chuai X; Wang W; Chen H; Deng Y; Wen B; Tan W
    Antiviral Res; 2014 Jan; 101():68-74. PubMed ID: 24239872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
    Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
    World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior transient exposure to interleukin-21 delivered by recombinant adeno-associated virus vector protects mice from hepatitis B virus persistence.
    Shen Z; Gao Z; Gu C; Wu J; Wang J; Zhang J; Xie Y; Liu J
    Antiviral Res; 2021 Jun; 190():105076. PubMed ID: 33865876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The doses of plasmid backbone plays a major role in determining the HBV clearance in hydrodynamic injection mouse model.
    Wang X; Zhu J; Zhang Y; Li Y; Ma T; Li Q; Xu J; Xu L
    Virol J; 2018 May; 15(1):89. PubMed ID: 29783985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the differences of two mouse models of hepatitis B virus infection by transduction with rAAV8-1. 3HBV].
    Wang G; Dong XY; Tian WH; Yu CJ; Zheng G; Gao J; Wang GJ; Wei GC; Zhou YS; Wu XB
    Bing Du Xue Bao; 2012 Sep; 28(5):541-7. PubMed ID: 23233931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous injection of naked plasmid DNA encoding hepatitis B virus (HBV) produces HBV and induces humoral immune response in mice.
    Suzuki T; Takehara T; Ohkawa K; Ishida H; Jinushi M; Miyagi T; Sasaki Y; Hayashi N
    Biochem Biophys Res Commun; 2003 Jan; 300(3):784-8. PubMed ID: 12507519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model.
    Li L; Li S; Zhou Y; Yang L; Zhou D; Yang Y; Lu M; Yang D; Song J
    Virol J; 2017 Oct; 14(1):205. PubMed ID: 29070073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factors.
    Chen SH; Wu HL; Kao JH; Hwang LH
    PLoS One; 2012; 7(5):e36984. PubMed ID: 22615863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated Response of Follicular Helper T Cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients.
    Wang X; Dong Q; Li Q; Li Y; Zhao D; Sun J; Fu J; Meng F; Lin H; Luan J; Liu B; Wang M; Wang FS; He F; Tang L
    Gastroenterology; 2018 Jun; 154(8):2222-2236. PubMed ID: 29544722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection.
    Yang PL; Althage A; Chung J; Chisari FV
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13825-30. PubMed ID: 12374864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of IL-21-expressing recombinant hepatitis B virus (HBV) as a therapeutic agent targeting persisting HBV infection.
    Shen Z; Wu J; Gao Z; Wang J; Zhu H; Mao R; Wang X; Zhang J; Xie Y; Liu J
    Theranostics; 2020; 10(12):5600-5612. PubMed ID: 32373234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus.
    Zhang Y; Cobleigh MA; Lian JQ; Huang CX; Booth CJ; Bai XF; Robek MD
    Gastroenterology; 2011 Nov; 141(5):1897-906. PubMed ID: 21708106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro.
    Zhu C; Zhang R; Liu L; Rasool ST; Mu Y; Sun W; Hao Q; Liu F; Zhu Y; Wu J
    Clin Immunol; 2009 Apr; 131(1):92-7. PubMed ID: 19081304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An HBV-tolerant immunocompetent model that effectively simulates chronic hepatitis B virus infection in mice.
    Yuan L; Wang T; Zhang Y; Liu X; Zhang T; Li X; Liu P; Wu K; Shih JW; Yuan Q; Cheng T; Xia N
    Exp Anim; 2016 Nov; 65(4):373-382. PubMed ID: 27264142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
    Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
    Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamics of HBV-DNA level in acute hepatitis B].
    Zhao H; Cao JH; Tian GS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):159-61. PubMed ID: 12870000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus middle surface antigen loss promotes clinical variant persistence in mouse models.
    Lin J; Li J; Xie P; Han Y; Yu D; Chen J; Zhang X
    Virulence; 2021 Dec; 12(1):2868-2882. PubMed ID: 34738866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.